Firy Inc. vs Novo Nordisk A/S — how do they compare? Firy Inc. trades at $10.21 (market cap $159.51M), while Novo Nordisk A/S trades at $45.93 (market cap $207.85B). The key difference: Novo Nordisk A/S is far larger — about 1303.1× Firy Inc.'s market cap, and Novo Nordisk A/S pays a 3.81% dividend while Firy Inc. pays none. Which is the better fit depends on your goals.
| FIRY | NVO | |
|---|---|---|
Market Cap | $159.51M | $207.85B |
Sector | Consumer Cyclical | Health |
52-Week High | $12.45 | $63.98 |
52-Week Low | $2.28 | $35.29 |
Enterprise Value | $103.18M | $222.55B |
Dividend Yield | — | 3.81% |
Trailing returns across standard periods
Latest headlines on both assets
Firy Inc. operates a mobile gaming platform in the United States, Israel, China, Malta, Hong Kong, Cyprus, and other international markets. The company operates through two segments: Skillz and RZR. Its Skillz platform enables game developers to monetize their content by integrating real-money tournaments, virtual prizes, and social competition features directly into multiplayer games.
Read more on FIRY →With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →